Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 9,417 | 8,730 | 2,101 | 8,493 | 10,164 |
| Cost of Goods | 1,792 | 1,659 | 1,505 | 1,461 | 1,523 |
| Gross Profit | 7,625 | 7,071 | 596 | 7,032 | 8,640 |
| Operating Expenses | 9,791 | 9,054 | 7,146 | 9,299 | 10,033 |
| Operating Income | -1,373 | -1,324 | -6,045 | -1,807 | -869 |
| Interest Expense | 91 | 61 | 136 | 19 | 22 |
| Other Income | 131 | 116 | 166 | 166 | 150 |
| Pre-tax Income | -1,334 | -1,269 | -6,015 | -1,660 | -741 |
| Income Tax | 5 | -81 | 4 | 4 | 4 |
| Net Income Continuous | -1,339 | -1,188 | -6,019 | -1,664 | -746 |
| Net Income Discontinuous | 772 | 1,147 | N/A | N/A | N/A |
| Minority Interests | -17 | 34 | -17 | -21 | -25 |
| Net Income | $-550 | $-74 | $-2,220 | $-1,643 | $-721 |
| EPS Basic Total Ops | -0.04 | 0.00 | -0.14 | -0.11 | -0.05 |
| EPS Basic Continuous Ops | -0.09 | -0.08 | -0.38 | -0.11 | -0.05 |
| EPS Basic Discontinuous Ops | 0.05 | 0.08 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.04 | 0.00 | -0.14 | -0.11 | -0.05 |
| EPS Diluted Continuous Ops | -0.09 | -0.08 | -0.38 | -0.11 | -0.05 |
| EPS Diluted Discontinuous Ops | 0.05 | 0.08 | N/A | N/A | N/A |
| EBITDA(a) | $-275 | $-248 | $-5,170 | $-1,094 | $-167 |